chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Metabolic function test, Painful respiration, Platelet count decreased, Pneumonia
Clinical narrative: Pfizer Dose 1 4/7/21 (ER8734) Pfizer Dose 2 4/28/21 (EW0170) Pfizer Dose 3 12/13/21 (lot NA) COVID Positive 1/17/22  1/19/22: Patient is a pleasant 65-year-old gentleman with past medical history of renal transplant 2 years ago secondary to rapidly progressive glomerular nephritis, hypertension, history of DVT and PE in, arthritis, chronic back pain who presented to the emergency department this evening with a chief complaint of shortness of breath.  Patient reports that he has been feeling unwell for about 4-5 days, 2 days ago had a positive COVID test. Patient is fully vaccinated against COVID including receiving his booster.  Patient endorses shortness of breath, cough, chest pain with deep breathing, fevers and chills, decreased appetite.  Today he contacted his renal transplant team at the hospital and they advised him to cut his dose of mycophenolate and half due to his illness.  In the emergency department the patient was found to be febrile with a temperature of a 101.3° F, hypoxic requiring 4 L of supplemental oxygen via nasal cannula. Blood pressures were also noted to be soft.  Workup including CMP, CBC, VBG, lactate, troponin, proBNP, and coags was notable for lactate elevated at 2.2, platelets low at 110, sodium 128, BUN 40, creatinine 1.97 (baseline is around 1.3-1.40).  Chest x-ray showed bilateral pneumonia consistent with a viral pneumonia.  While in the emergency department the patient received 2 L of IV fluid, dexamethasone, azithromycin, and Rocephin.   Past medical history is as noted above.  Reviewed patient's home medications with him, he reports compliance. No recent surgeries, within the last year has had surgery on his neck and lumbar spine.  Home family history noncontributory.  Patient lives alone but his daughter does live nearby.  Patient works part-time.  Patient is a former smoker.  Denies use of alcohol or recreational drugs.  2/20/22: Patient is a 65-year-old male who presented on 01/19/2022 with chief complaint of shortness of breath.  He was COVID positive.  He was fully vaccinated, but was immunosuppressed due to history of renal transplant for rapidly progressive glomerular nephritis.  He did poorly. He was intubated 01/24/2022.  He failed to wean and was eventually trached and pegged on 02/09/2022.  He started spiking fevers again on 02/09/2022 and infectious disease was consulted.  His infectious workup was negative and he was placed on fluconazole, vancomycin, and meropenem empirically by Infectious Disease.  Antimicrobials were discontinued at time of discharge.  Nephrology aided and management as well due to his history of renal transplant. Patient was managed in ICU until an LTAC bed was available. He was discharged to LTAC at select Hospital to continue current cares on 02/20/2022..
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia viral, Prohormone brain natriuretic peptide, Pyrexia, SARS-CoV-2 test positive, Tracheostomy
Clinical narrative: Pfizer Dose 1 4/7/21 (ER8734) Pfizer Dose 2 4/28/21 (EW0170) Pfizer Dose 3 12/13/21 (lot NA) COVID Positive 1/17/22  1/19/22: Patient is a pleasant 65-year-old gentleman with past medical history of renal transplant 2 years ago secondary to rapidly progressive glomerular nephritis, hypertension, history of DVT and PE in, arthritis, chronic back pain who presented to the emergency department this evening with a chief complaint of shortness of breath.  Patient reports that he has been feeling unwell for about 4-5 days, 2 days ago had a positive COVID test. Patient is fully vaccinated against COVID including receiving his booster.  Patient endorses shortness of breath, cough, chest pain with deep breathing, fevers and chills, decreased appetite.  Today he contacted his renal transplant team at the hospital and they advised him to cut his dose of mycophenolate and half due to his illness.  In the emergency department the patient was found to be febrile with a temperature of a 101.3° F, hypoxic requiring 4 L of supplemental oxygen via nasal cannula. Blood pressures were also noted to be soft.  Workup including CMP, CBC, VBG, lactate, troponin, proBNP, and coags was notable for lactate elevated at 2.2, platelets low at 110, sodium 128, BUN 40, creatinine 1.97 (baseline is around 1.3-1.40).  Chest x-ray showed bilateral pneumonia consistent with a viral pneumonia.  While in the emergency department the patient received 2 L of IV fluid, dexamethasone, azithromycin, and Rocephin.   Past medical history is as noted above.  Reviewed patient's home medications with him, he reports compliance. No recent surgeries, within the last year has had surgery on his neck and lumbar spine.  Home family history noncontributory.  Patient lives alone but his daughter does live nearby.  Patient works part-time.  Patient is a former smoker.  Denies use of alcohol or recreational drugs.  2/20/22: Patient is a 65-year-old male who presented on 01/19/2022 with chief complaint of shortness of breath.  He was COVID positive.  He was fully vaccinated, but was immunosuppressed due to history of renal transplant for rapidly progressive glomerular nephritis.  He did poorly. He was intubated 01/24/2022.  He failed to wean and was eventually trached and pegged on 02/09/2022.  He started spiking fevers again on 02/09/2022 and infectious disease was consulted.  His infectious workup was negative and he was placed on fluconazole, vancomycin, and meropenem empirically by Infectious Disease.  Antimicrobials were discontinued at time of discharge.  Nephrology aided and management as well due to his history of renal transplant. Patient was managed in ICU until an LTAC bed was available. He was discharged to LTAC at select Hospital to continue current cares on 02/20/2022..
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin
Clinical narrative: Pfizer Dose 1 4/7/21 (ER8734) Pfizer Dose 2 4/28/21 (EW0170) Pfizer Dose 3 12/13/21 (lot NA) COVID Positive 1/17/22  1/19/22: Patient is a pleasant 65-year-old gentleman with past medical history of renal transplant 2 years ago secondary to rapidly progressive glomerular nephritis, hypertension, history of DVT and PE in, arthritis, chronic back pain who presented to the emergency department this evening with a chief complaint of shortness of breath.  Patient reports that he has been feeling unwell for about 4-5 days, 2 days ago had a positive COVID test. Patient is fully vaccinated against COVID including receiving his booster.  Patient endorses shortness of breath, cough, chest pain with deep breathing, fevers and chills, decreased appetite.  Today he contacted his renal transplant team at the hospital and they advised him to cut his dose of mycophenolate and half due to his illness.  In the emergency department the patient was found to be febrile with a temperature of a 101.3° F, hypoxic requiring 4 L of supplemental oxygen via nasal cannula. Blood pressures were also noted to be soft.  Workup including CMP, CBC, VBG, lactate, troponin, proBNP, and coags was notable for lactate elevated at 2.2, platelets low at 110, sodium 128, BUN 40, creatinine 1.97 (baseline is around 1.3-1.40).  Chest x-ray showed bilateral pneumonia consistent with a viral pneumonia.  While in the emergency department the patient received 2 L of IV fluid, dexamethasone, azithromycin, and Rocephin.   Past medical history is as noted above.  Reviewed patient's home medications with him, he reports compliance. No recent surgeries, within the last year has had surgery on his neck and lumbar spine.  Home family history noncontributory.  Patient lives alone but his daughter does live nearby.  Patient works part-time.  Patient is a former smoker.  Denies use of alcohol or recreational drugs.  2/20/22: Patient is a 65-year-old male who presented on 01/19/2022 with chief complaint of shortness of breath.  He was COVID positive.  He was fully vaccinated, but was immunosuppressed due to history of renal transplant for rapidly progressive glomerular nephritis.  He did poorly. He was intubated 01/24/2022.  He failed to wean and was eventually trached and pegged on 02/09/2022.  He started spiking fevers again on 02/09/2022 and infectious disease was consulted.  His infectious workup was negative and he was placed on fluconazole, vancomycin, and meropenem empirically by Infectious Disease.  Antimicrobials were discontinued at time of discharge.  Nephrology aided and management as well due to his history of renal transplant. Patient was managed in ICU until an LTAC bed was available. He was discharged to LTAC at select Hospital to continue current cares on 02/20/2022..
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pruritus, Urticaria
Clinical narrative: Employee states, "Itching all over the body for several weeks."  Indicated that this started about 2 weeks after receiving 1st covid vaccine.  She had itching from head to feet and was treating with Benadryl and Zyrtec.  She indicated that she had little welts/bruising from scratching.  She did not see a provider regarding this reaction.   2nd covid vaccine given on 6/27/22, instructed to treat with Benadryl and Zyrtec as needed and seek medical attention if this reaction develops after 2nd vaccine.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Heart rate increased, Hyperhidrosis
Clinical narrative: lightheadness, high heart rate, diaphoresis, flushing
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lipoma, Subcutaneous biopsy abnormal
Clinical narrative: Lypoma development
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Burning sensation, Ear pain, Immediate post-injection reaction, Lymph node pain
Clinical narrative: Immediately when I received the vaccine I felt a burning sensation in two nerves, one on base of skull and one on top of skull. Subsided after one day. But came back a week later. Pain was also behind my ear and lymph node. My husband that is a doctor prescribed me VALTREX and prednisone, 5 days. Around a month later I felt burning in my left breast, severe enough that all clothing was sensitive. This lasted about 2 months.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Mammogram normal
Clinical narrative: Immediately when I received the vaccine I felt a burning sensation in two nerves, one on base of skull and one on top of skull. Subsided after one day. But came back a week later. Pain was also behind my ear and lymph node. My husband that is a doctor prescribed me VALTREX and prednisone, 5 days. Around a month later I felt burning in my left breast, severe enough that all clothing was sensitive. This lasted about 2 months.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Anaemia macrocytic, Anticoagulant therapy, Asthenia, Blood creatinine normal
Clinical narrative: Moderna Dose 1 3/5/21 (NA) Moderna Dose 2 4/9/21 (NA) COVID Positive 2/18/22  2/17/22: Patient is 84-year-old female coming from home with past medical history of chronic hypoxia on 3 L oxygen at home, atrial fibrillation anticoagulated with Eliquis, moderate aortic stenosis awaiting for TAVR, HFpEF, essential hypertension, pulmonary hypertension and gout. She was brought to the emergency room by family members for complaint of generalized weakness, decreased appetite, nausea and altered mental status.  Earlier this evening, patient was noted by her children not feeling herself.  Per family members, she was noted to be confused.  She was noted to be sliding down on her chair neck.  Patient reported she has been having poor appetite with belly pain for the past 2 days.  No report of nausea or vomiting. Patient reported dry cough.  No report of chest pain fever chills or rigors.  Patient is fully vaccinated for COVID-19.  No recent sick contacts.  Patient reported she has been having progressively worsening exertional dyspnea for the past 7-8 months.  She has moderate/severe aortic stenosis.  She is scheduled to have TAVR.  Patient denied use of tobacco products or alcohol products.  Upon evaluation at the emergency room, she was afebrile and hemodynamically stable.  She was maintaining 3 L of oxygen to maintain saturation which is her baseline.  Labs were significant for mild transaminitis, creatinine of 1.07 which is close to her baseline, proBNP of 2993, and macrocytic anemia with hemoglobin of 11.6 gram/deciliter. Nasopharyngeal swab was positive for COVID-19.  Chest x-ray revealed bilateral infiltrates.  Urinalysis revealed small leukocyte esterase.  Patient was recently treated for UTI. At the emergency room, patient received Lasix 40 mg IV and ceftriaxone 1 g IV.  3/6/22: -Continue with the current management.  -appreciate pulmonology recommendations.  -steroid taper per pulmonology  -Continue Precedex, will continue to wean the Precedex. Patient previously did poorly with Ativan and Haldol. Xanax through the NG tube p.r.n..  - monitor and replace electrolytes as indicated.  -appreciate pulmonology initiating thrombocytopenia workup.  -possible intubation later on 03/06/2022.  -Code status:  Full code   DVT ppx:  Patient was started on heparin drip on 03/05/2022 due to elevated D-dimer.   Disposition: Patient was made DNR by the family.  Patient expired on 03/06/2022 evening.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Confusional state, Cough, Death
Clinical narrative: Moderna Dose 1 3/5/21 (NA) Moderna Dose 2 4/9/21 (NA) COVID Positive 2/18/22  2/17/22: Patient is 84-year-old female coming from home with past medical history of chronic hypoxia on 3 L oxygen at home, atrial fibrillation anticoagulated with Eliquis, moderate aortic stenosis awaiting for TAVR, HFpEF, essential hypertension, pulmonary hypertension and gout. She was brought to the emergency room by family members for complaint of generalized weakness, decreased appetite, nausea and altered mental status.  Earlier this evening, patient was noted by her children not feeling herself.  Per family members, she was noted to be confused.  She was noted to be sliding down on her chair neck.  Patient reported she has been having poor appetite with belly pain for the past 2 days.  No report of nausea or vomiting. Patient reported dry cough.  No report of chest pain fever chills or rigors.  Patient is fully vaccinated for COVID-19.  No recent sick contacts.  Patient reported she has been having progressively worsening exertional dyspnea for the past 7-8 months.  She has moderate/severe aortic stenosis.  She is scheduled to have TAVR.  Patient denied use of tobacco products or alcohol products.  Upon evaluation at the emergency room, she was afebrile and hemodynamically stable.  She was maintaining 3 L of oxygen to maintain saturation which is her baseline.  Labs were significant for mild transaminitis, creatinine of 1.07 which is close to her baseline, proBNP of 2993, and macrocytic anemia with hemoglobin of 11.6 gram/deciliter. Nasopharyngeal swab was positive for COVID-19.  Chest x-ray revealed bilateral infiltrates.  Urinalysis revealed small leukocyte esterase.  Patient was recently treated for UTI. At the emergency room, patient received Lasix 40 mg IV and ceftriaxone 1 g IV.  3/6/22: -Continue with the current management.  -appreciate pulmonology recommendations.  -steroid taper per pulmonology  -Continue Precedex, will continue to wean the Precedex. Patient previously did poorly with Ativan and Haldol. Xanax through the NG tube p.r.n..  - monitor and replace electrolytes as indicated.  -appreciate pulmonology initiating thrombocytopenia workup.  -possible intubation later on 03/06/2022.  -Code status:  Full code   DVT ppx:  Patient was started on heparin drip on 03/05/2022 due to elevated D-dimer.   Disposition: Patient was made DNR by the family.  Patient expired on 03/06/2022 evening.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea exertional, Electrolyte substitution therapy, Feeling abnormal, Fibrin D dimer increased
Clinical narrative: Moderna Dose 1 3/5/21 (NA) Moderna Dose 2 4/9/21 (NA) COVID Positive 2/18/22  2/17/22: Patient is 84-year-old female coming from home with past medical history of chronic hypoxia on 3 L oxygen at home, atrial fibrillation anticoagulated with Eliquis, moderate aortic stenosis awaiting for TAVR, HFpEF, essential hypertension, pulmonary hypertension and gout. She was brought to the emergency room by family members for complaint of generalized weakness, decreased appetite, nausea and altered mental status.  Earlier this evening, patient was noted by her children not feeling herself.  Per family members, she was noted to be confused.  She was noted to be sliding down on her chair neck.  Patient reported she has been having poor appetite with belly pain for the past 2 days.  No report of nausea or vomiting. Patient reported dry cough.  No report of chest pain fever chills or rigors.  Patient is fully vaccinated for COVID-19.  No recent sick contacts.  Patient reported she has been having progressively worsening exertional dyspnea for the past 7-8 months.  She has moderate/severe aortic stenosis.  She is scheduled to have TAVR.  Patient denied use of tobacco products or alcohol products.  Upon evaluation at the emergency room, she was afebrile and hemodynamically stable.  She was maintaining 3 L of oxygen to maintain saturation which is her baseline.  Labs were significant for mild transaminitis, creatinine of 1.07 which is close to her baseline, proBNP of 2993, and macrocytic anemia with hemoglobin of 11.6 gram/deciliter. Nasopharyngeal swab was positive for COVID-19.  Chest x-ray revealed bilateral infiltrates.  Urinalysis revealed small leukocyte esterase.  Patient was recently treated for UTI. At the emergency room, patient received Lasix 40 mg IV and ceftriaxone 1 g IV.  3/6/22: -Continue with the current management.  -appreciate pulmonology recommendations.  -steroid taper per pulmonology  -Continue Precedex, will continue to wean the Precedex. Patient previously did poorly with Ativan and Haldol. Xanax through the NG tube p.r.n..  - monitor and replace electrolytes as indicated.  -appreciate pulmonology initiating thrombocytopenia workup.  -possible intubation later on 03/06/2022.  -Code status:  Full code   DVT ppx:  Patient was started on heparin drip on 03/05/2022 due to elevated D-dimer.   Disposition: Patient was made DNR by the family.  Patient expired on 03/06/2022 evening.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal tube insertion, Haemoglobin decreased, Hypertransaminasaemia, Inappropriate schedule of product administration, Laboratory test abnormal
Clinical narrative: Moderna Dose 1 3/5/21 (NA) Moderna Dose 2 4/9/21 (NA) COVID Positive 2/18/22  2/17/22: Patient is 84-year-old female coming from home with past medical history of chronic hypoxia on 3 L oxygen at home, atrial fibrillation anticoagulated with Eliquis, moderate aortic stenosis awaiting for TAVR, HFpEF, essential hypertension, pulmonary hypertension and gout. She was brought to the emergency room by family members for complaint of generalized weakness, decreased appetite, nausea and altered mental status.  Earlier this evening, patient was noted by her children not feeling herself.  Per family members, she was noted to be confused.  She was noted to be sliding down on her chair neck.  Patient reported she has been having poor appetite with belly pain for the past 2 days.  No report of nausea or vomiting. Patient reported dry cough.  No report of chest pain fever chills or rigors.  Patient is fully vaccinated for COVID-19.  No recent sick contacts.  Patient reported she has been having progressively worsening exertional dyspnea for the past 7-8 months.  She has moderate/severe aortic stenosis.  She is scheduled to have TAVR.  Patient denied use of tobacco products or alcohol products.  Upon evaluation at the emergency room, she was afebrile and hemodynamically stable.  She was maintaining 3 L of oxygen to maintain saturation which is her baseline.  Labs were significant for mild transaminitis, creatinine of 1.07 which is close to her baseline, proBNP of 2993, and macrocytic anemia with hemoglobin of 11.6 gram/deciliter. Nasopharyngeal swab was positive for COVID-19.  Chest x-ray revealed bilateral infiltrates.  Urinalysis revealed small leukocyte esterase.  Patient was recently treated for UTI. At the emergency room, patient received Lasix 40 mg IV and ceftriaxone 1 g IV.  3/6/22: -Continue with the current management.  -appreciate pulmonology recommendations.  -steroid taper per pulmonology  -Continue Precedex, will continue to wean the Precedex. Patient previously did poorly with Ativan and Haldol. Xanax through the NG tube p.r.n..  - monitor and replace electrolytes as indicated.  -appreciate pulmonology initiating thrombocytopenia workup.  -possible intubation later on 03/06/2022.  -Code status:  Full code   DVT ppx:  Patient was started on heparin drip on 03/05/2022 due to elevated D-dimer.   Disposition: Patient was made DNR by the family.  Patient expired on 03/06/2022 evening.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Mental status changes, Nausea, Posture abnormal, Prohormone brain natriuretic peptide increased
Clinical narrative: Moderna Dose 1 3/5/21 (NA) Moderna Dose 2 4/9/21 (NA) COVID Positive 2/18/22  2/17/22: Patient is 84-year-old female coming from home with past medical history of chronic hypoxia on 3 L oxygen at home, atrial fibrillation anticoagulated with Eliquis, moderate aortic stenosis awaiting for TAVR, HFpEF, essential hypertension, pulmonary hypertension and gout. She was brought to the emergency room by family members for complaint of generalized weakness, decreased appetite, nausea and altered mental status.  Earlier this evening, patient was noted by her children not feeling herself.  Per family members, she was noted to be confused.  She was noted to be sliding down on her chair neck.  Patient reported she has been having poor appetite with belly pain for the past 2 days.  No report of nausea or vomiting. Patient reported dry cough.  No report of chest pain fever chills or rigors.  Patient is fully vaccinated for COVID-19.  No recent sick contacts.  Patient reported she has been having progressively worsening exertional dyspnea for the past 7-8 months.  She has moderate/severe aortic stenosis.  She is scheduled to have TAVR.  Patient denied use of tobacco products or alcohol products.  Upon evaluation at the emergency room, she was afebrile and hemodynamically stable.  She was maintaining 3 L of oxygen to maintain saturation which is her baseline.  Labs were significant for mild transaminitis, creatinine of 1.07 which is close to her baseline, proBNP of 2993, and macrocytic anemia with hemoglobin of 11.6 gram/deciliter. Nasopharyngeal swab was positive for COVID-19.  Chest x-ray revealed bilateral infiltrates.  Urinalysis revealed small leukocyte esterase.  Patient was recently treated for UTI. At the emergency room, patient received Lasix 40 mg IV and ceftriaxone 1 g IV.  3/6/22: -Continue with the current management.  -appreciate pulmonology recommendations.  -steroid taper per pulmonology  -Continue Precedex, will continue to wean the Precedex. Patient previously did poorly with Ativan and Haldol. Xanax through the NG tube p.r.n..  - monitor and replace electrolytes as indicated.  -appreciate pulmonology initiating thrombocytopenia workup.  -possible intubation later on 03/06/2022.  -Code status:  Full code   DVT ppx:  Patient was started on heparin drip on 03/05/2022 due to elevated D-dimer.   Disposition: Patient was made DNR by the family.  Patient expired on 03/06/2022 evening.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Urinary tract infection, Urine analysis abnormal, Urine leukocyte esterase positive
Clinical narrative: Moderna Dose 1 3/5/21 (NA) Moderna Dose 2 4/9/21 (NA) COVID Positive 2/18/22  2/17/22: Patient is 84-year-old female coming from home with past medical history of chronic hypoxia on 3 L oxygen at home, atrial fibrillation anticoagulated with Eliquis, moderate aortic stenosis awaiting for TAVR, HFpEF, essential hypertension, pulmonary hypertension and gout. She was brought to the emergency room by family members for complaint of generalized weakness, decreased appetite, nausea and altered mental status.  Earlier this evening, patient was noted by her children not feeling herself.  Per family members, she was noted to be confused.  She was noted to be sliding down on her chair neck.  Patient reported she has been having poor appetite with belly pain for the past 2 days.  No report of nausea or vomiting. Patient reported dry cough.  No report of chest pain fever chills or rigors.  Patient is fully vaccinated for COVID-19.  No recent sick contacts.  Patient reported she has been having progressively worsening exertional dyspnea for the past 7-8 months.  She has moderate/severe aortic stenosis.  She is scheduled to have TAVR.  Patient denied use of tobacco products or alcohol products.  Upon evaluation at the emergency room, she was afebrile and hemodynamically stable.  She was maintaining 3 L of oxygen to maintain saturation which is her baseline.  Labs were significant for mild transaminitis, creatinine of 1.07 which is close to her baseline, proBNP of 2993, and macrocytic anemia with hemoglobin of 11.6 gram/deciliter. Nasopharyngeal swab was positive for COVID-19.  Chest x-ray revealed bilateral infiltrates.  Urinalysis revealed small leukocyte esterase.  Patient was recently treated for UTI. At the emergency room, patient received Lasix 40 mg IV and ceftriaxone 1 g IV.  3/6/22: -Continue with the current management.  -appreciate pulmonology recommendations.  -steroid taper per pulmonology  -Continue Precedex, will continue to wean the Precedex. Patient previously did poorly with Ativan and Haldol. Xanax through the NG tube p.r.n..  - monitor and replace electrolytes as indicated.  -appreciate pulmonology initiating thrombocytopenia workup.  -possible intubation later on 03/06/2022.  -Code status:  Full code   DVT ppx:  Patient was started on heparin drip on 03/05/2022 due to elevated D-dimer.   Disposition: Patient was made DNR by the family.  Patient expired on 03/06/2022 evening.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: PATIENT RECEIVED FIRST DOSE ON 06/15/2021 AND CAME BACK  BEFORE 21 DAYS TO GET SECOND DOSE. WAS ADMINISTERED SECOND DOSE BEFORE FILLING OUT CARD AND SEEING DATE.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, Death, Endotracheal intubation, Hyperthermia
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on  6/11/21, 7/12/21 and 1/04/22. Presented to the ED via EMS after being found unresponsive in her home, O2 sat of 80% and placed on O2 by EMS.  Intubated in ED, fever 105.8 rectally, cooling was initiated. Leukocytosis, acute kidney injury, lactic acidosis. Admitted for UT, AKI, resp failure, AMS, hyperthermia and severe sepsis. Administered IV fluids and abx, transferred to ICU. Previously elected DNR status. Tx'd with decadron, ampicillin, and cefepime. Expired on 6/24/22.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Intensive care, Lactic acidosis, Leukocytosis, Mental status changes
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on  6/11/21, 7/12/21 and 1/04/22. Presented to the ED via EMS after being found unresponsive in her home, O2 sat of 80% and placed on O2 by EMS.  Intubated in ED, fever 105.8 rectally, cooling was initiated. Leukocytosis, acute kidney injury, lactic acidosis. Admitted for UT, AKI, resp failure, AMS, hyperthermia and severe sepsis. Administered IV fluids and abx, transferred to ICU. Previously elected DNR status. Tx'd with decadron, ampicillin, and cefepime. Expired on 6/24/22.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Respiratory failure, SARS-CoV-2 test positive, Sepsis, Unresponsive to stimuli
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Moderna Vaccines on  6/11/21, 7/12/21 and 1/04/22. Presented to the ED via EMS after being found unresponsive in her home, O2 sat of 80% and placed on O2 by EMS.  Intubated in ED, fever 105.8 rectally, cooling was initiated. Leukocytosis, acute kidney injury, lactic acidosis. Admitted for UT, AKI, resp failure, AMS, hyperthermia and severe sepsis. Administered IV fluids and abx, transferred to ICU. Previously elected DNR status. Tx'd with decadron, ampicillin, and cefepime. Expired on 6/24/22.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Anticoagulation drug level below therapeutic, Apnoea, Asthenia, Blood creatinine increased
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6204) Pfizer Dose 2 4/2/21 (EN6198) Pfizer Dose 3 10/26/21 (FF2593) COVID Positive 1/26/22  1/26/22: A 74-year-old female with past medical history of chronic atrial fibrillation on anticoagulation with Coumadin, hypertension, stage III CKD, CAD, PAD, chronic HFrEF, COPD not on home oxygen, hx ppm implantation is sent to ED by ambulance from nursing home for generalized edema.  Patient states that she does not remember why she is sent here but she states she was kept on oxygen at the facility.  At this time she feels much better, denies chest pain or shortness of breath, feels tired and weak.  As per the EMR she was blood culture generalized edema, she was saturating 93% on 2 L oxygen.  Patient is vaccinated for COVID-19.  She was recently discharged from the hospital on 01/21/2022 after she was treated for dehydration, diuretics were held at that time.   In the ED, she was afebrile, pulse ox 96 on room air, blood pressure stable.  Blood work is significant for mild elevation in BUN and creatinine, leukocytosis, elevated proBNP, with mild lactic acidosis.  Urinalysis positive for nitrate.  1/31/22: Patient was admitted and started on IV diuretics as well as empiric IV antibiotics.  She was diuresed and given increased doses of Coumadin for subtherapeutic INR and developed supratherapeutic INR.  Did not diurese well on intermittent IV Lasix and was switched to a Lasix infusion on hospital day 3. Urine culture was negative and antibiotics were stopped.  She was continued on the Lasix infusion.  Lasix infusion was stopped on hospital day 5. She was noted to have increasing confusion and CT head was obtained given her supratherapeutic INR and returned negative.  At approximately 6:55 a.m. in the morning on hospital day 6 she was found to be unresponsive and apneic and a code was called.  ACLS was started and patient received multiple doses of epinephrine and was intubated by the ED physician.  ROSC was obtained and she was transferred to the ICU, she soon went into PEA arrest despite being on 2 pressors and ACLS was resumed.  A pulse was not obtained after the 2nd arrest and time of death was called at 8:02 a.m. on 01/31/2022.  Pupils were fixed and dilated and no heart or breath sounds were present.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture, Blood test, Blood urea increased, Breath sounds absent, COVID-19
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6204) Pfizer Dose 2 4/2/21 (EN6198) Pfizer Dose 3 10/26/21 (FF2593) COVID Positive 1/26/22  1/26/22: A 74-year-old female with past medical history of chronic atrial fibrillation on anticoagulation with Coumadin, hypertension, stage III CKD, CAD, PAD, chronic HFrEF, COPD not on home oxygen, hx ppm implantation is sent to ED by ambulance from nursing home for generalized edema.  Patient states that she does not remember why she is sent here but she states she was kept on oxygen at the facility.  At this time she feels much better, denies chest pain or shortness of breath, feels tired and weak.  As per the EMR she was blood culture generalized edema, she was saturating 93% on 2 L oxygen.  Patient is vaccinated for COVID-19.  She was recently discharged from the hospital on 01/21/2022 after she was treated for dehydration, diuretics were held at that time.   In the ED, she was afebrile, pulse ox 96 on room air, blood pressure stable.  Blood work is significant for mild elevation in BUN and creatinine, leukocytosis, elevated proBNP, with mild lactic acidosis.  Urinalysis positive for nitrate.  1/31/22: Patient was admitted and started on IV diuretics as well as empiric IV antibiotics.  She was diuresed and given increased doses of Coumadin for subtherapeutic INR and developed supratherapeutic INR.  Did not diurese well on intermittent IV Lasix and was switched to a Lasix infusion on hospital day 3. Urine culture was negative and antibiotics were stopped.  She was continued on the Lasix infusion.  Lasix infusion was stopped on hospital day 5. She was noted to have increasing confusion and CT head was obtained given her supratherapeutic INR and returned negative.  At approximately 6:55 a.m. in the morning on hospital day 6 she was found to be unresponsive and apneic and a code was called.  ACLS was started and patient received multiple doses of epinephrine and was intubated by the ED physician.  ROSC was obtained and she was transferred to the ICU, she soon went into PEA arrest despite being on 2 pressors and ACLS was resumed.  A pulse was not obtained after the 2nd arrest and time of death was called at 8:02 a.m. on 01/31/2022.  Pupils were fixed and dilated and no heart or breath sounds were present.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Cardio-respiratory arrest, Computerised tomogram head normal, Confusional state, Culture urine negative, Death
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6204) Pfizer Dose 2 4/2/21 (EN6198) Pfizer Dose 3 10/26/21 (FF2593) COVID Positive 1/26/22  1/26/22: A 74-year-old female with past medical history of chronic atrial fibrillation on anticoagulation with Coumadin, hypertension, stage III CKD, CAD, PAD, chronic HFrEF, COPD not on home oxygen, hx ppm implantation is sent to ED by ambulance from nursing home for generalized edema.  Patient states that she does not remember why she is sent here but she states she was kept on oxygen at the facility.  At this time she feels much better, denies chest pain or shortness of breath, feels tired and weak.  As per the EMR she was blood culture generalized edema, she was saturating 93% on 2 L oxygen.  Patient is vaccinated for COVID-19.  She was recently discharged from the hospital on 01/21/2022 after she was treated for dehydration, diuretics were held at that time.   In the ED, she was afebrile, pulse ox 96 on room air, blood pressure stable.  Blood work is significant for mild elevation in BUN and creatinine, leukocytosis, elevated proBNP, with mild lactic acidosis.  Urinalysis positive for nitrate.  1/31/22: Patient was admitted and started on IV diuretics as well as empiric IV antibiotics.  She was diuresed and given increased doses of Coumadin for subtherapeutic INR and developed supratherapeutic INR.  Did not diurese well on intermittent IV Lasix and was switched to a Lasix infusion on hospital day 3. Urine culture was negative and antibiotics were stopped.  She was continued on the Lasix infusion.  Lasix infusion was stopped on hospital day 5. She was noted to have increasing confusion and CT head was obtained given her supratherapeutic INR and returned negative.  At approximately 6:55 a.m. in the morning on hospital day 6 she was found to be unresponsive and apneic and a code was called.  ACLS was started and patient received multiple doses of epinephrine and was intubated by the ED physician.  ROSC was obtained and she was transferred to the ICU, she soon went into PEA arrest despite being on 2 pressors and ACLS was resumed.  A pulse was not obtained after the 2nd arrest and time of death was called at 8:02 a.m. on 01/31/2022.  Pupils were fixed and dilated and no heart or breath sounds were present.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Endotracheal intubation, Fatigue, Generalised oedema, Heart sounds abnormal
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6204) Pfizer Dose 2 4/2/21 (EN6198) Pfizer Dose 3 10/26/21 (FF2593) COVID Positive 1/26/22  1/26/22: A 74-year-old female with past medical history of chronic atrial fibrillation on anticoagulation with Coumadin, hypertension, stage III CKD, CAD, PAD, chronic HFrEF, COPD not on home oxygen, hx ppm implantation is sent to ED by ambulance from nursing home for generalized edema.  Patient states that she does not remember why she is sent here but she states she was kept on oxygen at the facility.  At this time she feels much better, denies chest pain or shortness of breath, feels tired and weak.  As per the EMR she was blood culture generalized edema, she was saturating 93% on 2 L oxygen.  Patient is vaccinated for COVID-19.  She was recently discharged from the hospital on 01/21/2022 after she was treated for dehydration, diuretics were held at that time.   In the ED, she was afebrile, pulse ox 96 on room air, blood pressure stable.  Blood work is significant for mild elevation in BUN and creatinine, leukocytosis, elevated proBNP, with mild lactic acidosis.  Urinalysis positive for nitrate.  1/31/22: Patient was admitted and started on IV diuretics as well as empiric IV antibiotics.  She was diuresed and given increased doses of Coumadin for subtherapeutic INR and developed supratherapeutic INR.  Did not diurese well on intermittent IV Lasix and was switched to a Lasix infusion on hospital day 3. Urine culture was negative and antibiotics were stopped.  She was continued on the Lasix infusion.  Lasix infusion was stopped on hospital day 5. She was noted to have increasing confusion and CT head was obtained given her supratherapeutic INR and returned negative.  At approximately 6:55 a.m. in the morning on hospital day 6 she was found to be unresponsive and apneic and a code was called.  ACLS was started and patient received multiple doses of epinephrine and was intubated by the ED physician.  ROSC was obtained and she was transferred to the ICU, she soon went into PEA arrest despite being on 2 pressors and ACLS was resumed.  A pulse was not obtained after the 2nd arrest and time of death was called at 8:02 a.m. on 01/31/2022.  Pupils were fixed and dilated and no heart or breath sounds were present.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Intensive care, Lactic acidosis, Leukocytosis, Life support
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6204) Pfizer Dose 2 4/2/21 (EN6198) Pfizer Dose 3 10/26/21 (FF2593) COVID Positive 1/26/22  1/26/22: A 74-year-old female with past medical history of chronic atrial fibrillation on anticoagulation with Coumadin, hypertension, stage III CKD, CAD, PAD, chronic HFrEF, COPD not on home oxygen, hx ppm implantation is sent to ED by ambulance from nursing home for generalized edema.  Patient states that she does not remember why she is sent here but she states she was kept on oxygen at the facility.  At this time she feels much better, denies chest pain or shortness of breath, feels tired and weak.  As per the EMR she was blood culture generalized edema, she was saturating 93% on 2 L oxygen.  Patient is vaccinated for COVID-19.  She was recently discharged from the hospital on 01/21/2022 after she was treated for dehydration, diuretics were held at that time.   In the ED, she was afebrile, pulse ox 96 on room air, blood pressure stable.  Blood work is significant for mild elevation in BUN and creatinine, leukocytosis, elevated proBNP, with mild lactic acidosis.  Urinalysis positive for nitrate.  1/31/22: Patient was admitted and started on IV diuretics as well as empiric IV antibiotics.  She was diuresed and given increased doses of Coumadin for subtherapeutic INR and developed supratherapeutic INR.  Did not diurese well on intermittent IV Lasix and was switched to a Lasix infusion on hospital day 3. Urine culture was negative and antibiotics were stopped.  She was continued on the Lasix infusion.  Lasix infusion was stopped on hospital day 5. She was noted to have increasing confusion and CT head was obtained given her supratherapeutic INR and returned negative.  At approximately 6:55 a.m. in the morning on hospital day 6 she was found to be unresponsive and apneic and a code was called.  ACLS was started and patient received multiple doses of epinephrine and was intubated by the ED physician.  ROSC was obtained and she was transferred to the ICU, she soon went into PEA arrest despite being on 2 pressors and ACLS was resumed.  A pulse was not obtained after the 2nd arrest and time of death was called at 8:02 a.m. on 01/31/2022.  Pupils were fixed and dilated and no heart or breath sounds were present.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Nitrite urine present, Polyuria, Prohormone brain natriuretic peptide increased, Pulseless electrical activity, Pupil fixed
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6204) Pfizer Dose 2 4/2/21 (EN6198) Pfizer Dose 3 10/26/21 (FF2593) COVID Positive 1/26/22  1/26/22: A 74-year-old female with past medical history of chronic atrial fibrillation on anticoagulation with Coumadin, hypertension, stage III CKD, CAD, PAD, chronic HFrEF, COPD not on home oxygen, hx ppm implantation is sent to ED by ambulance from nursing home for generalized edema.  Patient states that she does not remember why she is sent here but she states she was kept on oxygen at the facility.  At this time she feels much better, denies chest pain or shortness of breath, feels tired and weak.  As per the EMR she was blood culture generalized edema, she was saturating 93% on 2 L oxygen.  Patient is vaccinated for COVID-19.  She was recently discharged from the hospital on 01/21/2022 after she was treated for dehydration, diuretics were held at that time.   In the ED, she was afebrile, pulse ox 96 on room air, blood pressure stable.  Blood work is significant for mild elevation in BUN and creatinine, leukocytosis, elevated proBNP, with mild lactic acidosis.  Urinalysis positive for nitrate.  1/31/22: Patient was admitted and started on IV diuretics as well as empiric IV antibiotics.  She was diuresed and given increased doses of Coumadin for subtherapeutic INR and developed supratherapeutic INR.  Did not diurese well on intermittent IV Lasix and was switched to a Lasix infusion on hospital day 3. Urine culture was negative and antibiotics were stopped.  She was continued on the Lasix infusion.  Lasix infusion was stopped on hospital day 5. She was noted to have increasing confusion and CT head was obtained given her supratherapeutic INR and returned negative.  At approximately 6:55 a.m. in the morning on hospital day 6 she was found to be unresponsive and apneic and a code was called.  ACLS was started and patient received multiple doses of epinephrine and was intubated by the ED physician.  ROSC was obtained and she was transferred to the ICU, she soon went into PEA arrest despite being on 2 pressors and ACLS was resumed.  A pulse was not obtained after the 2nd arrest and time of death was called at 8:02 a.m. on 01/31/2022.  Pupils were fixed and dilated and no heart or breath sounds were present.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Unresponsive to stimuli, Urine analysis
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6204) Pfizer Dose 2 4/2/21 (EN6198) Pfizer Dose 3 10/26/21 (FF2593) COVID Positive 1/26/22  1/26/22: A 74-year-old female with past medical history of chronic atrial fibrillation on anticoagulation with Coumadin, hypertension, stage III CKD, CAD, PAD, chronic HFrEF, COPD not on home oxygen, hx ppm implantation is sent to ED by ambulance from nursing home for generalized edema.  Patient states that she does not remember why she is sent here but she states she was kept on oxygen at the facility.  At this time she feels much better, denies chest pain or shortness of breath, feels tired and weak.  As per the EMR she was blood culture generalized edema, she was saturating 93% on 2 L oxygen.  Patient is vaccinated for COVID-19.  She was recently discharged from the hospital on 01/21/2022 after she was treated for dehydration, diuretics were held at that time.   In the ED, she was afebrile, pulse ox 96 on room air, blood pressure stable.  Blood work is significant for mild elevation in BUN and creatinine, leukocytosis, elevated proBNP, with mild lactic acidosis.  Urinalysis positive for nitrate.  1/31/22: Patient was admitted and started on IV diuretics as well as empiric IV antibiotics.  She was diuresed and given increased doses of Coumadin for subtherapeutic INR and developed supratherapeutic INR.  Did not diurese well on intermittent IV Lasix and was switched to a Lasix infusion on hospital day 3. Urine culture was negative and antibiotics were stopped.  She was continued on the Lasix infusion.  Lasix infusion was stopped on hospital day 5. She was noted to have increasing confusion and CT head was obtained given her supratherapeutic INR and returned negative.  At approximately 6:55 a.m. in the morning on hospital day 6 she was found to be unresponsive and apneic and a code was called.  ACLS was started and patient received multiple doses of epinephrine and was intubated by the ED physician.  ROSC was obtained and she was transferred to the ICU, she soon went into PEA arrest despite being on 2 pressors and ACLS was resumed.  A pulse was not obtained after the 2nd arrest and time of death was called at 8:02 a.m. on 01/31/2022.  Pupils were fixed and dilated and no heart or breath sounds were present.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Dysgeusia, Dyspnoea exertional, Fatigue
Clinical narrative: Starting 06/18/2022, I had congestion which worsened and then included coughing, wheezing and a fever of 101 for a few days and body aches. I tested positive on 06/18/2022. The body aches were the worst around Tuesday 06/21/2022 to the point where I didn't want to move and my joints hurt a lot as well. My congestion gradually got better up until yesterday. My aches are becoming more infrequent. My fever has resolved. I still have coughing spells and have only needed to use my inhaler 1x or 2x. I have been taking mucinex to help with congestion and staying hydrated. On day 5, I still tested positive. I will go back this coming Tuesday (07/05/2022) and I am still experiencing fatigue, feeling out of breath if I exert myself and coughing spells. I am continuing mucinex to keep the mucous thin so that I don't have trouble breathing. My congestion is not fully resolved but its getting better and the mucinex is helping that. Also, all the food I ate tasted metallic and as of today its better but still present. Also, my face was very sensitive and my normal face wash bothered my skin.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Mobility decreased, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: Starting 06/18/2022, I had congestion which worsened and then included coughing, wheezing and a fever of 101 for a few days and body aches. I tested positive on 06/18/2022. The body aches were the worst around Tuesday 06/21/2022 to the point where I didn't want to move and my joints hurt a lot as well. My congestion gradually got better up until yesterday. My aches are becoming more infrequent. My fever has resolved. I still have coughing spells and have only needed to use my inhaler 1x or 2x. I have been taking mucinex to help with congestion and staying hydrated. On day 5, I still tested positive. I will go back this coming Tuesday (07/05/2022) and I am still experiencing fatigue, feeling out of breath if I exert myself and coughing spells. I am continuing mucinex to keep the mucous thin so that I don't have trouble breathing. My congestion is not fully resolved but its getting better and the mucinex is helping that. Also, all the food I ate tasted metallic and as of today its better but still present. Also, my face was very sensitive and my normal face wash bothered my skin.